O’Brien Figure 1B.
O’Brien Figure 1B. Estimated progression-free survival rates at 30 months analyzed by Sokal score: patients with the lowest scores (better prognosis group) had the highest progression-free survival rates. IRIS/0106 trial.

Estimated progression-free survival rates at 30 months analyzed by Sokal score: patients with the lowest scores (better prognosis group) had the highest progression-free survival rates. IRIS/0106 trial.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal